Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

Treatment algorithm for oral anticoagulant and antiplatelet therapy in epistaxis patients.

Biggs TC, Baruah P, Mainwaring J, Harries PG, Salib RJ.

J Laryngol Otol. 2013 May;127(5):483-8. doi: 10.1017/S0022215113000492. Epub 2013 Apr 2.

PMID:
23544790
2.

Epistaxis in patients taking oral anticoagulant and antiplatelet medication: prospective cohort study.

Smith J, Siddiq S, Dyer C, Rainsbury J, Kim D.

J Laryngol Otol. 2011 Jan;125(1):38-42. doi: 10.1017/S0022215110001921. Epub 2010 Sep 16.

PMID:
20843406
3.

Should prophylactic antibiotics be used routinely in epistaxis patients with nasal packs?

Biggs TC, Nightingale K, Patel NN, Salib RJ.

Ann R Coll Surg Engl. 2013 Jan;95(1):40-2. doi: 10.1308/003588413X13511609954734.

5.

Does the continuation of warfarin change management outcomes in epistaxis patients?

Bola S, Marsh R, Braggins S, Potter C, Hickey S.

J Laryngol Otol. 2016 Mar;130(3):256-60. doi: 10.1017/S0022215115003424. Epub 2015 Dec 28.

PMID:
26707504
6.

Maintenance of anticoagulant and antiplatelet agents for patients undergoing peribulbar anesthesia and vitreoretinal surgery.

Passemard M, Koehrer P, Juniot A, Bron AM, Creuzot-Garcher C.

Retina. 2012 Oct;32(9):1868-73.

PMID:
22495328
7.

Antiplatelet and anticoagulation therapy in vitreoretinal surgery.

Oh J, Smiddy WE, Kim SS.

Am J Ophthalmol. 2011 Jun;151(6):934-939.e3. doi: 10.1016/j.ajo.2010.09.035. Epub 2011 Mar 16.

PMID:
21411057
8.

The role of surgical audit in improving patient management; nasal haemorrhage: an audit study.

Upile T, Jerjes W, Sipaul F, El Maaytah M, Nouraei SA, Singh S, Hopper C, Wright A.

BMC Surg. 2007 Sep 13;7:19.

9.

Maintenance of perioperative antiplatelet and anticoagulant therapy for vitreoretinal surgery.

Ryan A, Saad T, Kirwan C, Keegan DJ, Acheson RW.

Clin Experiment Ophthalmol. 2013 May-Jun;41(4):387-95. doi: 10.1111/ceo.12017. Epub 2012 Dec 10.

PMID:
23094982
10.

Routine coagulation screening in the management of emergency admission for epistaxis--is it necessary?

Thaha MA, Nilssen EL, Holland S, Love G, White PS.

J Laryngol Otol. 2000 Jan;114(1):38-40.

PMID:
10789409
11.

Assessment of practice patterns of perioperative management of antiplatelet and anticoagulant therapy in interventional pain management.

Manchikanti L, Benyamin RM, Swicegood JR, Falco FJ, Datta S, Pampati V, Fellows B, Hirsch JA.

Pain Physician. 2012 Nov-Dec;15(6):E955-68. Review.

12.
13.
14.
15.

A retrospective study to assess the morbidity associated with transurethral prostatectomy in patients on antiplatelet or anticoagulant drugs.

Taylor K, Filgate R, Guo DY, Macneil F.

BJU Int. 2011 Nov;108 Suppl 2:45-50. doi: 10.1111/j.1464-410X.2011.10686.x.

16.
17.
18.

The effects of clopidogrel (Plavix) and other oral anticoagulants on early hip fracture surgery.

Collinge CA, Kelly KC, Little B, Weaver T, Schuster RD.

J Orthop Trauma. 2012 Oct;26(10):568-73.

PMID:
22441640
19.

Epistaxis and oral anticoagulant therapy.

Choudhury N, Sharp HR, Mir N, Salama NY.

Rhinology. 2004 Jun;42(2):92-7. Review.

PMID:
15224636
20.

The Warfarin and Antiplatelet Therapy in Heart Failure trial (WATCH): rationale, design, and baseline patient characteristics.

Massie BM, Krol WF, Ammon SE, Armstrong PW, Cleland JG, Collins JF, Ezekowitz M, Jafri SM, O'Connor CM, Packer M, Schulman KA, Teo K, Warren S.

J Card Fail. 2004 Apr;10(2):101-12.

PMID:
15101020
Items per page

Supplemental Content

Write to the Help Desk